Use case · Science & health
Research for science and health markets
Drug approvals, trial readouts and published findings. These markets resolve on a regulator's decision or a paper, and the gap between a preprint and a result is where they are won and lost.
What this covers. MarketClaims reads the coverage of approvals, trial readouts and published findings behind each science market, turns it into dated claims with their sources attached, and keeps a preliminary result apart from a confirmed one. The venue's settlement wording comes with it, because what counts as the finding is usually the whole question.
Published research on these markets
Free to read, sources attached, nothing behind a form.
What we read for these markets
The primary coverage a science & health question actually turns on.
Approvals and decisions
Coverage of what a regulator actually decided, with the date it was announced.
Published, not preprint
Reporting that distinguishes a peer-reviewed result from an early one.
Readouts as reported
What a readout stated, kept apart from what a release claimed about it.
Questions this research answers
Each one resolves on a stated rule. The evidence has to speak to that rule, not to the mood.
- Has the approval been granted, or is the decision still pending?The claims that establish a decision, dated, with the outlet that reported it.
- Is this a published result or a preprint?Each claim labelled with what it actually rests on.
- What does this market count as the trial succeeding?The venue's wording, quoted, with the ambiguities named.
See it on a market you actually care about.
Paste any Polymarket or Kalshi URL and we will read the news behind it.
Ten free analyses. No card required. Research only, not financial advice.